Rheumatology

Large vessel vasculitis

Questions discussed in this category

How do you manage a patient with giant cell arteritis treated with weekly tocilizumab and low dose glucocorticoid who develops sudden vision loss?

2 Answers available

How long do you continue steroid-sparing agents such as tocilizumab for GCA once the disease is in remission off steroids?

1 Answer available

At what point in GCA management do you typically introduce tocilizumab?

2 Answers available

How do you manage incidentally identified chemotherapy-associated aortitis/large vessel vasculitis?

1 Answer available

How do you counsel Takayasu patients on their prognosis?

2 Answers available

Papers discussed in this category

BJR Case Rep, 2018 Sep 08

A case of aortitis during cisplatin-based chemotherapy for cervical cancer.

Ann Intern Med, 2020 Sep 22

Risk for Serious Infection With Low-Dose Glucocorticoids in Patients With Rheumatoid Arthritis : A Cohort Study.

Curr Rheumatol Rep, 2020 Oct 16

Morbidity and Mortality of Large-Vessel Vasculitides.

N Engl J Med,

Trial of Tocilizumab in Giant-Cell Arteritis.

Lancet, 2016 Mar 04

Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial.

Arthritis Res Ther, 2021 Mar 22

Vision loss in patients with giant cell arteritis treated with tocilizumab.

Related Topics in Rheumatology